ASCO GI 2023 Conference Coverage

 

ASCO GI 2023 Conference Coverage
A

ASCO GI 2023 Final Surgical Salvage Results From OPERA Phase 3 Randomised Trial: Do Nonoperative Modality Treatments of Rectal Cancer Compromise the Chance of Cure?

By ASCO GI 2023 Conference Coverage FEATURING Arthur Sun Myint
By ASCO GI 2023 Conference Coverage FEATURING Arthur Sun Myint
221 views
February 10, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Featured Video

13:36
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss
Videos
07:46

ASCO GI 2023 Phase II Clinical Trial to Study the Use of Cabozantini…

ASCO GI 2023 Conference Coverage

S. L. Chan

506 views
12:04

ASCO GI 2023 Preliminary Efficacy and Correlative Results of the Pha…

ASCO GI 2023 Conference Coverage

K. Spencer

96 views
06:17

ASCO GI 2023 INTEGRATE IIa Randomised, Double-Blind, Phase III Study…

ASCO GI 2023 Conference Coverage

N. Pavlakis

147 views
06:25

ASCO GI 2023 Overall Survival in Gastrointestinal Neuroendocrine Tum…

ASCO GI 2023 Conference Coverage

B. Laderian

164 views
05:13

ASCO GI 2023 Primary Endpoint Results of a Randomized, Double-Blind,…

ASCO GI 2023 Conference Coverage

J. Furuse

56 views
13:21

ASCO GI 2023 TIMES Trial: Advancing Precision Immunotherapy for Gast…

ASCO GI 2023 Conference Coverage

D. Zeng

150 views
09:24

ASCO GI 2023 Randomized Phase II VELO Clinical Trial: Panitumumab + …

ASCO GI 2023 Conference Coverage

S. Napolitano

146 views
11:02

ASCO GI 2023 3-Year Follow-Up From CheckMate 649: Nivo + Chemo vs. C…

ASCO GI 2023 Conference Coverage

Y. Y. Janjigian

598 views
30:57

ASCO GI 2023 Final Surgical Salvage Results From OPERA Phase 3 Rando…

ASCO GI 2023 Conference Coverage

A. Sun Myint

221 views
08:54

ASCO GI 2023 CRC Highlights: Phase 3 SUNLIGHT & PARADIGM Trials

ASCO GI 2023 Conference Coverage

A. Venook

513 views
09:02

ASCO GI 2023: A Study of Pembro in Combination With Y90 Radioemboliz…

ASCO GI 2023 Conference Coverage

A. Somasundaram

161 views
05:56

ASCO GI 2023 Phase II IMMULAB Trial: IO With Pembro in Combination W…

ASCO GI 2023 Conference Coverage

A. Vogel

101 views
05:26

ASCO GI 2023 Results From the TAPUR Study: Pertuzumab + Trastuzumab …

ASCO GI 2023 Conference Coverage

T. Cannon

166 views
10:19

ASCO GI 2023 Promoting Multidisciplinary Care for Patients With Unre…

ASCO GI 2023 Conference Coverage

A. Baron

55 views
07:46

FGFR2-Amplified Gastroesophageal Adenocarcinoma Is a Distinct Genomi…

ASCO GI 2023 Conference Coverage

B. Shariff

61 views
06:59

ASCO GI 2023 CCTG HE.1 - Phase 3 Study: Palliative RT for Symptomati…

ASCO GI 2023 Conference Coverage

L. Dawson

80 views
09:43

ASCO GI 2023 NRG/RTOG 1112 Randomized Phase 3 Study: Sorafenib vs. S…

ASCO GI 2023 Conference Coverage

L. Dawson

442 views
05:32

ASCO GI 2023 Continuous Maintenance Capecitabine Dosing for Advanced…

ASCO GI 2023 Conference Coverage

R. Mukherji

128 views
20:09

ASCO GI 2023 Debate: For a Fit Patient With Unresectable Metastatic …

ASCO GI 2023 Conference Coverage

K. Shiu

149 views
04:06

ASCO GI 2023 Phase Ib OBERTO-201 Study: Evaluating Safety, Tolerabil…

ASCO GI 2023 Conference Coverage

J. Hubbard

43 views
06:08

ASCO GI 2023 Survival Outcomes and Functional Results of VOLTAGE-A: …

ASCO GI 2023 Conference Coverage

Y. Tsukada

78 views
23:58

ASCO GI 2023 Key Studies

ASCO GI 2023 Conference Coverage

R. Kim, R. Mehta

3.1K views
10:41

ASCO GI 2023 NAPOLI-3 Randomized, Open-Label Phase 3 Study: Liposoma…

ASCO GI 2023 Conference Coverage

Z. Wainberg

398 views
07:49

ASCO GI 2023 Preliminary Clinical Results of the NERDY Study: Immuno…

ASCO GI 2023 Conference Coverage

A. Anna Prete

74 views
05:32

ASCO GI 2023 Phase 3 Randomized SWOG 1815 Trial: Gemcitabine, Cispla…

ASCO GI 2023 Conference Coverage

R. Shroff

255 views
05:29

ASCO GI 2023 Phase 3 BREAKWATER Study Safety Lead-In: Encorafenib + …

ASCO GI 2023 Conference Coverage

S. Kopetz

663 views
16:19

ASCO GI 2023 Exploring Immunotherapy Combinations for DDR-Deficient …

ASCO GI 2023 Conference Coverage

K. Reiss Binder

134 views
08:15

ASCO GI 2023 Zanidatamab + Chemo as 1L Treatment for HER2-Expressing…

ASCO GI 2023 Conference Coverage

E. Elimova

126 views
04:20

ASCO GI 2023 Final Results of the Phase II RE-ExPEL Study: Ramucirum…

ASCO GI 2023 Conference Coverage

T. Oliver Götze

171 views
12:31

ASCO GI 2023 29-Month Follow-Up From CheckMate 648: Nivo + Chemo or …

ASCO GI 2023 Conference Coverage

K. Kato

108 views
07:20

ASCO GI 2023 ctDNA Informs Clinical Practice in Patients With Recurr…

ASCO GI 2023 Conference Coverage

R. Mehta

505 views
06:52

ASCO GI 2023 Multicenter, Single-Arm, Multi-Cohort, Phase II INFINIT…

ASCO GI 2023 Conference Coverage

F. Pietrantonio

222 views
11:46

ASCO GI 2023 Debate: For a Fit Patient With Unresectable Metastatic …

ASCO GI 2023 Conference Coverage

A. Shergill

199 views
09:47

ASCO GI 2023 Neoadjuvant Immunotherapy in Localized dMMR CRC

ASCO GI 2023 Conference Coverage

S. Chakrabarti

179 views
09:12

ASCO GI 2023 Comparative Analysis of the Molecular Profile and Tumor…

ASCO GI 2023 Conference Coverage

A. Alqahtani

203 views
04:46

ASCO GI 2023 Confidence Study: Effectiveness & Safety of Encorafenib…

ASCO GI 2023 Conference Coverage

A. Fernandez Montes

94 views
07:58

ASCO GI 2023 ctDNA Dynamics and Clinical Outcome in mCRC Patients Un…

ASCO GI 2023 Conference Coverage

M. Ghidini

103 views
09:41

ASCO GI 2023 New Prognostic Index of Advanced Gastric Cancer Using t…

ASCO GI 2023 Conference Coverage

D. Takahari

126 views
04:41

ASCO GI 2023 Characterization of Long-Term Survivors in the TOPAZ-1 …

ASCO GI 2023 Conference Coverage

M. Bouattour

304 views
12:06

ASCO GI 2023 Surgical Viewpoint on Non-Operative Management of Recta…

ASCO GI 2023 Conference Coverage

T. Konishi

80 views
27:37

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

ASCO GI 2023 Conference Coverage

N. Uboha, A. Turk, K. Spencer, M. Cecchini

4.1K views
05:34

ASCO GI 2023 Biomarker Study of The Phase III PARADIGM Trial: Negati…

ASCO GI 2023 Conference Coverage

K. Shitara

328 views
07:51

ASCO GI 2023 Phase 3 SPOTLIGHT Study Primary Results: Zolbetuximab +…

ASCO GI 2023 Conference Coverage

K. Shitara

489 views
07:40

ASCO GI 2023 Kinetics of Postoperative Circulating cfDNA and Impact …

ASCO GI 2023 Conference Coverage

S. Cohen

69 views
06:32

ASCO GI 2023 Analysis of HLA Gene Expression in Patients With dMMR/M…

ASCO GI 2023 Conference Coverage

H. Lenz

105 views
07:43

ASCO GI 2023 ctDNA for Response Assessment in Patients With Anal Can…

ASCO GI 2023 Conference Coverage

J. Alvarez

130 views
06:55

ASCO GI 2023 Evaluation of Clinical Benefit and PFS Ratio of Targete…

ASCO GI 2023 Conference Coverage

M. Niger

90 views
05:19

ASCO GI 2023 Phase 3 STELLAR-303 Study: XL092 in Combination With At…

ASCO GI 2023 Conference Coverage

J. Hecht

391 views
10:26

Phase 3 Randomized SUNLIGHT Study: Trifluridine/Tipiracil + Bevacizu…

ASCO GI 2023 Conference Coverage

J. Tabernero

533 views
06:16

ASCO GI 2023 on Organ Preservation and Total Neoadjuvant Therapy for…

ASCO GI 2023 Conference Coverage

P. Romesser

360 views
06:55

ASCO GI 2023 Results From a Phase 1a/1b Study: Botensilimab, a Novel…

ASCO GI 2023 Conference Coverage

A. El-Khoueiry

157 views
10:41

ASCO GI 2023 Phase 2, Randomized, Double-Blind, Placebo-Controlled I…

ASCO GI 2023 Conference Coverage

A. El-Khoueiry

202 views
08:47

ASCO GI 2023 Use of ctDNA for Early Assessment of Treatment Response…

ASCO GI 2023 Conference Coverage

P. Kasi

120 views
13:36

ASCO GI 2023 CTCs as Liquid Biopsies in Patients With mCRC vs. Other…

ASCO GI 2023 Conference Coverage

P. Kasi

149 views
06:32

ASCO GI 2023 Randomized Phase III FIRE-4 study (AIO KRK-0114): Inves…

ASCO GI 2023 Conference Coverage

S. Stintzing

361 views
06:28

ASCO GI 2023 Survival Analysis of the Phase II Randomized DEEPER Tri…

ASCO GI 2023 Conference Coverage

Y. Sunakawa

309 views